Correlation Between Aarey Drugs and Nalwa Sons

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aarey Drugs and Nalwa Sons at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aarey Drugs and Nalwa Sons into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aarey Drugs Pharmaceuticals and Nalwa Sons Investments, you can compare the effects of market volatilities on Aarey Drugs and Nalwa Sons and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aarey Drugs with a short position of Nalwa Sons. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aarey Drugs and Nalwa Sons.

Diversification Opportunities for Aarey Drugs and Nalwa Sons

-0.8
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Aarey and Nalwa is -0.8. Overlapping area represents the amount of risk that can be diversified away by holding Aarey Drugs Pharmaceuticals and Nalwa Sons Investments in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nalwa Sons Investments and Aarey Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aarey Drugs Pharmaceuticals are associated (or correlated) with Nalwa Sons. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nalwa Sons Investments has no effect on the direction of Aarey Drugs i.e., Aarey Drugs and Nalwa Sons go up and down completely randomly.

Pair Corralation between Aarey Drugs and Nalwa Sons

Assuming the 90 days trading horizon Aarey Drugs is expected to generate 3.34 times less return on investment than Nalwa Sons. But when comparing it to its historical volatility, Aarey Drugs Pharmaceuticals is 1.16 times less risky than Nalwa Sons. It trades about 0.05 of its potential returns per unit of risk. Nalwa Sons Investments is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  313,845  in Nalwa Sons Investments on September 12, 2024 and sell it today you would earn a total of  545,460  from holding Nalwa Sons Investments or generate 173.8% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy99.18%
ValuesDaily Returns

Aarey Drugs Pharmaceuticals  vs.  Nalwa Sons Investments

 Performance 
       Timeline  
Aarey Drugs Pharmace 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aarey Drugs Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest unsteady performance, the Stock's basic indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.
Nalwa Sons Investments 

Risk-Adjusted Performance

18 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Nalwa Sons Investments are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting basic indicators, Nalwa Sons unveiled solid returns over the last few months and may actually be approaching a breakup point.

Aarey Drugs and Nalwa Sons Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aarey Drugs and Nalwa Sons

The main advantage of trading using opposite Aarey Drugs and Nalwa Sons positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aarey Drugs position performs unexpectedly, Nalwa Sons can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nalwa Sons will offset losses from the drop in Nalwa Sons' long position.
The idea behind Aarey Drugs Pharmaceuticals and Nalwa Sons Investments pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Equity Valuation
Check real value of public entities based on technical and fundamental data
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Transaction History
View history of all your transactions and understand their impact on performance
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities